Cargando…
Research diagnostic criteria for Alzheimer’s disease: findings from the LipiDiDiet randomized controlled trial
BACKGROUND: To explore the utility of the International Working Group (IWG)-1 criteria in recruitment for Alzheimer’s disease (AD) clinical trials, we applied the more recently proposed research diagnostic criteria to individuals enrolled in a randomized controlled prevention trial (RCT) and assesse...
Autores principales: | Rosenberg, Anna, Solomon, Alina, Soininen, Hilkka, Visser, Pieter Jelle, Blennow, Kaj, Hartmann, Tobias, Kivipelto, Miia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995792/ https://www.ncbi.nlm.nih.gov/pubmed/33766132 http://dx.doi.org/10.1186/s13195-021-00799-3 |
Ejemplares similares
-
36‐month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease
por: Soininen, Hilkka, et al.
Publicado: (2020) -
24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial
por: Soininen, Hilkka, et al.
Publicado: (2017) -
The LipiDiDiet trial: what does it add to the current evidence for Fortasyn Connect in early Alzheimer’s disease?
por: Rasmussen, Jill
Publicado: (2019) -
History of Medically Treated Diabetes and Risk of Alzheimer Disease in a Nationwide Case-Control Study
por: Tolppanen, Anna-Maija, et al.
Publicado: (2013) -
Midlife Healthy-Diet Index and Late-Life Dementia and Alzheimer's Disease
por: Eskelinen, Marjo H., et al.
Publicado: (2011)